Lv5
868 积分 2024-07-04 加入
Targeting the Hippo pathway in cancer
1天前
已完结
Novel Compounds as TEAD Inhibitors for Treating Cancer
1天前
已完结
Pan-cancer analysis, cell and animal experiments revealing TEAD4 as a tumor promoter in ccRCC
5天前
已完结
Pan-Transcriptional Enhanced Associated Domain Palmitoylation Pocket Covalent Inhibitor
6天前
已完结
Structure-based optimization of TEAD inhibitors: Exploring a novel subpocket near Glu347 for the treatment of NF2-mutant cancer
6天前
已完结
Development of Novel Indole-Based Covalent Inhibitors of TEAD as Potential Antiliver Cancer Agents
10天前
已完结
A Transformable Specific-Responsive Peptide for One-Step Synergistic Therapy of Bladder Cancer
2个月前
已完结
Transformable ECM Deprivation System Effectively Suppresses Renal Cell Carcinoma by Reversing Anoikis Resistance and Increasing Chemotherapy Sensitivity
2个月前
已完结
YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial
2个月前
已完结
The Multi-Faceted Landscape of TEAD Inhibition: a 2017-2025 Patent and Literature Review
2个月前
已完结
皖公网安备34019202002308
